Humacyte logo

Humacyte

HUMA | NASDAQ
Chart Builder DCF Calculator
$0.50
-$0.02 (-4.12%)
At close: Oct 5, 2026, 4:00 PM ET
-4.12%

Rating

Updated: Sep 8, 2026
23.5
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $84M
1D Range
0.48 0.52
52W Range
0.48 2.55

Valuation (TTM)

PE -0.98
PB 2.69
EV/EBITDA -0.88

Valuation (NTM)

Forward PE N/A
Forward PEG -0.03
Price Target $2.00
Loading financial charts...

Profile

Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array o...

Sector Healthcare
Industry Biotechnology
Employees 184
IPO Date Dec 1, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$2.00
Upside
+300.00%
Buy (5)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.